Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPing An Biomedical Co Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q2 2026 | N/A | $1.91 | N/A | N/A | $4.80 M |
| 12/31/2025 | Q1 2026 | N/A | $1.91 | N/A | N/A | $4.80 M |
| 09/30/2025 | Q4 2025 | N/A | -$9.20 | N/A | N/A | $7.96 M |
| 06/30/2025 | Q3 2025 | N/A | -$9.20 | N/A | N/A | $7.96 M |
| 03/31/2025 | Q2 2025 | N/A | -$4.80 | N/A | N/A | $9.12 M |
| 12/31/2024 | Q1 2025 | N/A | -$4.80 | N/A | N/A | $9.12 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ping An Biomedical Co Ltd. Earnings: FAQ's
The conference call for Ping An Biomedical Co Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Ping An Biomedical Co Ltd.'s latest earnings report can be read online.
Ping An Biomedical Co Ltd. (:PASW) has a recorded annual revenue of $34.15 M.
Ping An Biomedical Co Ltd. (:PASW) has a recorded net income of $-12,829,206.Ping An Biomedical Co Ltd. has generated $-27.6 earnings per share over the last four quarters.
Ping An Biomedical Co Ltd. (:PASW) has a price-to-earnings ratio of -0.76 and price/earnings-to-growth ratio is 0.01.